Nanostring Technologies reported $-35927000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agilent A:US $ 466M 3M
Becton, Dickinson and BDX:US $ 1362M 105M
Bio Rad Laboratories BIO:US $ 175.52M 38.34M
Bio Techne TECH:US $ 111.91M 18.1M
Bruker BRKR:US $ 125.1M 27.1M
Catalent CTLT:US $ 315M 39M
Charles River Laboratories CRL:US $ 224.08M 52.84M
Danaher DHR:US $ 2737M 32M
Exact Sciences EXAS:US $ -129.33M 38.31M
Fluidigm FLDM:US $ -23.4M 15.47M
Hologic HOLX:US $ 700.1M 45.3M
Illumina ILMN:US $ 275M 145M
IQVIA Holdings Inc IQV:US $ 757M 27M
Mettler Toledo International MTD:US 257.33M 71.78M
Myriad Genetics MYGN:US $ -1.9M 34.1M
Nanostring Technologies NSTG:US $ -35.93M 10.1M
Pacific Biosciences Of California PACB:US $ -75.03M 13.24M
Perkinelmer PKI:US $ 408.78M 39.75M
Repligen RGEN:US $ 72.61M 7.34M
Thermo Fisher Scientific TMO:US $ 3682M 304M
Waters WAT:US $ 228.13M 73.03M